Medical Device Delivery Delays Due to the Global Semiconductor Shortage
First written in FY2022-Q3. 1 of 2 entries say "Mitigated", first in FY2023-Q1. Latest entry: FY2023-Q1.
0 other companies' latest entry also says "Mitigated".
Not enough years or companies yet to draw the terrain. The sentences above are computed from what exists.
- FY2023-Q1MitigatedAnnual report
「Against this backdrop, in the medical equipment distribution business, the Group's core business, growth in low-invasive treatment equipment and supplies, including endoscope-related products, as well as radiation therapy equipment and diagnostic equipment and supplies, including ultrasound diagnostic systems, was driven by continued capital investment by medical institutions funded by COVID-19 countermeasure subsidies, the easing of the impact of the semiconductor shortage that had occurred at the end of the previous fiscal year, and increased receipt and sale of products whose delivery had been delayed.」
As the impact of the semiconductor shortage that had emerged at the end of the previous fiscal year eased, and the receipt and sale of products with delayed deliveries progressed, the risk of supply delays caused by the semiconductor shortage was partly reduced. - FY2022-Q3First statedAnnual report
「The global semiconductor shortage has also affected medical device manufacturing, resulting in delays in medical device deliveries.」
The global semiconductor shortage was identified as a new supply risk affecting medical equipment manufacturing, with delivery delays actually occurring.